USGI Medical Receives FDA Approval to Expand US Pilot Study Evaluating Incisionless Weight Loss Procedure – POSE 2.0

June 8, 2020

USGI Medical states POSE 2.0 uses USGI Medical’s Incisionless Operating Platform (IOP) to strategically place durable Snowshoe Suture Anchors in gastric tissue to both shorten and narrow the stomach. The procedure provides volumetric gastric restriction, like that achieved by a surgical sleeve gastrectomy, without amputating part of the stomach.  Patients treated with the POSE procedure typically return to work in just one to two days without any scars or signs of surgery.

During the first stage of the US pilot study, Principal Investigator, Professor Barham Abu Dayyeh, MD, MPH at the Mayo Clinic (Rochester, MN) treated five patients with the POSE 2.0 procedure. Participants in the Investigational Device Exemption (IDE) study are evaluated for weight loss and other efficacy assessments and receive lifestyle and nutritional care through the primary endpoint of one year.

Dr. Abu Dayyeh commented, “This procedure is very reproducible. It’s quite impressive how every patient receives the same new smaller stomach configuration throughout the series contributing to ease of use and consistent positive results.”

To date at the midpoint follow-up of 6 months, patients treated with the POSE 2.0 procedure achieved on average 12.5% total body weight loss (TBWL). All patients responded to treatment with a clinically meaningful TBWL >5% and 60% of patients achieved TBWL >13%. Thus far, all patients are fully satisfied with their outcomes to date and no adverse events were reported during both the procedure as well as throughout the 6-month follow-up.

Given the promising results obtained so far, on April 14, 2020, USGI Medical, Inc. received approval from the FDA for expansion of the pilot study to 4 US institutions and 35 US subjects.

Mr. Carlos Babini, CEO of USGI Medical stated, “We are most pleased with reaching this milestone and continuing our commitment to safe and effective outcomes for patients undergoing the POSE 2.0 procedure.  We look forward to progressing towards a US-based pivotal study and FDA submission for an obesity indication for our label.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy